Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,364,241
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
39,775,602
-
Shares change
-
+2,402,710
-
Total reported value, excl. options
-
$140,807,820
-
Value change
-
+$5,279,129
-
Put/Call ratio
-
15%
-
Number of buys
-
46
-
Number of sells
-
40
-
Price
-
$3.54
Institutional Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q4 2024
As of 31 Dec 2024 scPharmaceuticals Inc. - Common Stock (SCPH) had 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 39,775,602 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Rubric Capital Management LP, AIGH Capital Management LLC, KING LUTHER CAPITAL MANAGEMENT CORP, BlackRock, Inc., VANGUARD GROUP INC, MORGAN STANLEY, SUVRETTA CAPITAL MANAGEMENT, LLC, J. Goldman & Co LP, and 5AM Venture Management, LLC.
This table shows 84 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.